Search - tctmd.com

Displaying 421 - 440 of 628

Sort: Relevancy | Date

News Industry News

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

October 15, 2015

Presentation TCT 2015

Paravalvular Leak Closure: New Devices and the State of the Art

Presenter: Ziyad M. Hijazi, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

Presenter: Ziyad M. Hijazi, Robert J. Sommer, John P. Cheatham

October 14, 2015

Presentation TCT 2015

ADO II and Other Approaches to PDA Closure

Presenter: Ziyad M. Hijazi, Robert J. Sommer, Lars Sondergaard

October 14, 2015

Presentation TCT 2015

Melody, Edwards, and Venus Valves: Lessons Learned and Future Directions

Presenter: Ziyad M. Hijazi, Robert J. Sommer, Thomas K. Jones

October 14, 2015

Presentation TCT 2015

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Presenter: David W.M. Muller, John F. Rhodes, Zahid Amin

October 14, 2015

Presentation TCT 2015

Acroredis, Iris Fit, and CARAG ASD Occluder

Presenter: David W.M. Muller, John F. Rhodes, Horst Sievert

October 14, 2015

Presentation TCT 2015

GSO: Good-bye Helex

Presenter: David W.M. Muller, John F. Rhodes

October 14, 2015

Presentation TCT 2015

PFO and Hypoxemia: Patient Selection

Presenter: David Hildick-Smith, Jonathan M. Tobis, John C. Messenger

October 14, 2015

Presentation TCT 2015

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Presenter: David Hildick-Smith, Jonathan M. Tobis, Franz X. Kleber

October 14, 2015

Presentation TCT 2015

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

Presenter: David Hildick-Smith, Jonathan M. Tobis, Robert J. Sommer

October 14, 2015

Presentation TCT 2015

PRIMA Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

PREMIUM Trial: Lessons Learned

Presenter: David Hildick-Smith, Jonathan M. Tobis

October 14, 2015

Presentation TCT 2015

Update on the ROPE Study: Emerging Insights

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

Presentation TCT 2015

Risk of Paradoxical Embolism With Pacemaker Leads

Presenter: John D. Carroll, Mark Reisman, Samir R. Kapadia

October 14, 2015

Presentation TCT 2015

Clinical Practice in 2015: When Closure Is and Is Not Justified

Presenter: John D. Carroll, Mark Reisman

October 14, 2015

Presentation TCT 2015

Meta-analysis of PFO Stroke Trials

Presenter: John D. Carroll, Mark Reisman, David E. Thaler

October 14, 2015

News Conference News TCT 2015

PFO Closure Still Attracts Controversy

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

Presenter: John P. Cheatham, Carlos Pedra, Jonathan M. Tobis

October 13, 2015

News Conference News TCT 2015

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

October 11, 2015

Advertisement

Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients

Paravalvular Leak Closure: New Devices and the State of the Art

The State of the Art of Transcatheter Treatment of Aortic Coarctation in Adults

ADO II and Other Approaches to PDA Closure

Melody, Edwards, and Venus Valves: Lessons Learned and Future Directions

The FDA-Mandated Postapproval Study of the Amplazter ASO Device

Acroredis, Iris Fit, and CARAG ASD Occluder

GSO: Good-bye Helex

PFO and Hypoxemia: Patient Selection

Paradoxical Embolic Myocardial Infarction: Analysis of More Than 6500 Patients With AMI

Are There Certain Patients for Whom PFO Closure for Migraine Should Now Be Considered Acceptable?

PRIMA Trial: Lessons Learned

PREMIUM Trial: Lessons Learned

Update on the ROPE Study: Emerging Insights

Risk of Paradoxical Embolism With Pacemaker Leads

Clinical Practice in 2015: When Closure Is and Is Not Justified

Meta-analysis of PFO Stroke Trials

PFO Closure Still Attracts Controversy

TCT 30: PREMIUM Trial Double-blind Study of Percutaneous Closure of Patent Foramen Ovale With the AMPLATZER PFO Occluder as a Treatment for Migraine With or Without Aura

PREMIUM Trial: PFO Closure Primarily Benefits Migraine Patients With Aura

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content